These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19962672)

  • 1. Corporate control and professional prerogative: an unresolved tension for pharmacists.
    Clark BE
    Res Social Adm Pharm; 2009 Dec; 5(4):299-301. PubMed ID: 19962672
    [No Abstract]   [Full Text] [Related]  

  • 2. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy ownership in Canada: implications for the authority and autonomy of community pharmacy managers.
    Dobson RT; Perepelkin J
    Res Social Adm Pharm; 2011 Dec; 7(4):347-58. PubMed ID: 21272538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care at a crossroad: what will the pharmacists' role be?
    Gurney MK
    Res Social Adm Pharm; 2009 Dec; 5(4):302-4. PubMed ID: 19962673
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolution of the Pharmacy Benefit Manager/Community Pharmacy Relationship: An Opportunity for Success.
    Taddei-Allen P
    J Manag Care Spec Pharm; 2020 Jun; 26(6):708-710. PubMed ID: 32463767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacy in the United Arab Emirates: characteristics and workforce issues.
    Hasan S; Sulieman H; Chapman C; Stewart K; Kong DC
    Int J Pharm Pract; 2011 Dec; 19(6):392-9. PubMed ID: 22060234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the implementation of a novel optimizing care model in the community pharmacy setting.
    Hohmeier KC; Desselle SP
    J Am Pharm Assoc (2003); 2019; 59(3):310-318. PubMed ID: 30940516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ownership type on role orientation, role affinity, and role conflict among community pharmacy managers and owners in Canada.
    Perepelkin J; Dobson RT
    Res Social Adm Pharm; 2010 Dec; 6(4):280-92. PubMed ID: 21111386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' awareness of Australia's health care reforms and their beliefs and attitudes about their current and future roles.
    Mak VS; Clark A; Poulsen JH; Udengaard KU; Gilbert AL
    Int J Pharm Pract; 2012 Feb; 20(1):33-40. PubMed ID: 22236178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical care in community pharmacies: practice and research in Germany.
    Eickhoff C; Schulz M
    Ann Pharmacother; 2006 Apr; 40(4):729-35. PubMed ID: 16569798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacy strives for continuity of care.
    Sellers JA
    Am J Health Syst Pharm; 1998 Apr; 55(7):635-7. PubMed ID: 9558415
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of community pharmacies in North West England: an observational study.
    Mackridge AJ; Stokes EC; Gray NJ
    Int J Pharm Pract; 2017 Apr; 25(2):172-175. PubMed ID: 27198475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Market dynamics of community pharmacies in Minnesota, U.S. from 1992 through 2012.
    Schommer JC; Yusuf AA; Hadsall RS
    Res Social Adm Pharm; 2014; 10(1):217-31. PubMed ID: 23669250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-Care Testing in Community Pharmacies: Keys to Success From Pennsylvania Pharmacists.
    Steltenpohl EA; Barry BK; Coley KC; McGivney MS; Olenak JL; Berenbrok LA
    J Pharm Pract; 2018 Dec; 31(6):629-635. PubMed ID: 29034781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of pharmacists' role functions across various nations: The importance of screening.
    Inoue Y; Takikawa M; Morita Y; Takao K; Kanamoto I; Sugibayashi K
    Res Social Adm Pharm; 2016; 12(2):347-54. PubMed ID: 26072001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the impact of evolving health policy on independent pharmacy ownership in England.
    Gidman W
    Pharm World Sci; 2010 Aug; 32(4):488-95. PubMed ID: 20454857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building capacity to implement cognitive pharmaceutical services: Quantifying the needs of community pharmacies.
    Feletto E; Wilson LK; Roberts AS; Benrimoj SI
    Res Social Adm Pharm; 2010 Sep; 6(3):163-73. PubMed ID: 20813330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
    Hanes CA; Wong KK; Saini B
    Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.